Evidence map›Paper›PMID 38791222›Full record

ArticleInternational journal of molecular sciences2024

Fei Fei, Caitlin Caporale, Lisa Chang, Barbara K Fortini, Haris Ali, Diana Bell, Anthony Stein, Guido Marcucci, Milhan Telatar, Michelle Afkhami

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Genes · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Fei FeiDepartment of Pathology, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
Caitlin CaporaleBreast Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.ORCID 0009-0004-3882-6358
Lisa ChangDepartment of Pathology, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
Barbara K FortiniKeck Graduate Institute, Claremont, CA 91711, USA.ORCID 0000-0003-3230-2604
Haris AliDepartment of Hematology & Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
Diana BellDepartment of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.
Anthony SteinDepartment of Hematology & Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
Guido MarcucciDepartment of Hematology & Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
Milhan TelatarDepartment of Pathology, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
Michelle AfkhamiDepartment of Pathology, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.ORCID 0000-0001-5830-6158

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

High-Throughput Nucleotide SequencingLeukemia, Myeloid, AcuteMutationProto-Oncogene Proteins B-rafAdultAgedAged, 80 and overDioxygenasesDNA-Binding ProteinsFemaleHumansJanus Kinase 2MaleMiddle AgedPrognosisProto-Oncogene ProteinsASXL1 protein, humanBRAF protein, humanDioxygenasesDNA-Binding ProteinsJAK2 protein, humanJanus Kinase 2Proto-Oncogene ProteinsProto-Oncogene Proteins B-rafRepressor ProteinsTET2 protein, humanBRAF mutationmyeloid neoplasmsnext-generation sequencing

Identifiers

PMID38791222
PMCPMC11121641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.